Member Info for Smartinvestment

Last year the company released FY22 on 3rd February so should be soon

Good to see the share price rising again.

With the full year results just around the corner my main focus will be the gross margin as we already have a pretty accurate idea of revenue. I think the market will be looking for improving gross margins and if that occurs hopefully that will be a positive catalyst.

I have to admit I have considered selling some of my holding last year but I am glad that I didn’t. Having endured this long I know I would kick myself for selling out and then seeing the company fulfil its potential over coming months and years. With an enhanced management team in place, strategic links with Bemis and tons of cash to grow revenue it’s a perfect storm brewing IMO.

Having absorbed the video I have a few observations:

1. John Shaw and his team 100% read the comments on here, so we do have a voice. I am grateful that they have responded to many of the issues we have been talking about.

2. The development and progress of SAP and Bio-Asterix are clearly going to be key to the future success of ITX.

3. Looking forward to the new website and enhanced digital marketing (about time!)

4. The company is clearly a value play at 1.4 x revenue. 5. Interesting to hear JS discussing the acquisition question for the first time. If you notice, he didn’t rule it out. But hinted at SAP and bioasterix devpt being needed first to increase recognition of the powerful Itaconix platform.

The part below about analyst’s reducing Itaconix revenue expectations for 2024 and 2025 (which I had missed) explains why we saw the recent drop in share price.

Itaconix PLC (AIM:ITX, OTCQB:ITXXF) CEO John Shaw speaks to Thomas Warner from Proactive about how the company, which makes plant-based ingredients for consumer products, is positioned heading into the new year.

Shaw expresses optimism about the company's future and shared insights into its current status and strategies. Shaw highlights Itaconix's efforts to enhance its trading ability in the U.S., including overcoming challenges with share consolidations and brokerage protocols. He addresses concerns about the company's decreased share price, emphasising the intrinsic value created through significant advancements over the past two years.

Shaw points out the company's relatively low market valuation compared to its revenue growth and potential in the plant-based chemical sector. Shaw downplays the notion of Itaconix as an acquisition target, focusing instead on the company's commitment to expanding its technology platform, which has significant potential and a robust customer project pipeline. He also dismissed the idea of moving to another market, citing satisfaction with the current investor base.

Addressing analysts' reducing of Itaconix's revenue expectations for 2024 and 2025, Shaw clarified that this does not indicate a downturn in business. He attributes adjustments to the normalisation of inflated chemical prices and reassured that Itaconix's profitability and commercial milestones remain on track.

Looking ahead to 2024, Shaw expressed confidence in the company's strong position, driven by revenue growth, a solid customer pipeline, and new initiatives, including a focus on digital marketing and smaller accounts.

Interesting that John Shaw’s purchase yesterday was at $1.73 (about £1.37)

I agreed Bod

Whilst I may be ridiculed by one or two members of this board for topping up I hope to have the last laugh. I was happy to buy ITX at up to 11p (550p) in the past, and since then the company has made incredible progress so I am certainly willing to buy at 120p. In fact I will keep adding when I can because I am more confident than ever that the share price will take off at some point next year.

Surfie you say speculation on a Take Over isn’t the likely outcome, then what is?

Do you really think those who sank £11m into Itaconix at 255p are gonna sit back and take a 60% loss?

LV it should be in the January full update for 2023 year end.

75,658 shares traded today compared to just 13,688 on the day of the trading update last week. Someone has clearly decided to dump a lot of shares today.

I firmly believe the timing of the RNS was very odd. They always update in January. Why give an update 4 weeks early?

I tell you there is something going on behind the scenes. We know they have plenty of cash and revenue is growing and gross margins improving so financially things look rosy. But the big investors can’t be happy with their losses. I disagree that they are willing to wait 10 years. Every day I see the financial markets move billions between stocks and bonds to on the slightest whiff of a change in interest rates. These guys are not patient they are greedy.

I genuinely believe John Shaw released the RNS early in a desperate attempt to boost the share price because of what is happening in the background. Pure speculation on my behalf, but just me reading between the lines.

I’ve just added another 800 shares at £1.224 in the hope that my hunch about a hostile takeover comes true. The company is so ridiculously cheap both in terms of turnover and IP and I don’t believe the large investors can possibly be happy with what they are seeing.

This is seriously disturbing. Share price gets hammered after every positive trading update which makes me smell a rat.

The only positive is that the current share price makes the company a sitting duck for a hostile takeover.

Was yesterday’s update really to please little private investors like us? I don’t think so.

There are big fish out there who invested a lot of money at 260p. They are down 50%. They will only be patient so long, before they want to see a return on their investment.

Yesterday’s unscheduled Trading Update and recent token Director buys could be interpreted as desperate attempts to get the share price up quickly.

If so, ask yourselves why the urgency?

Could it be they are fighting a proposed hostile takeover. Let’s face it any medium (or large) sized company could snap Itaconix up at 300p a share and who of us would currently say ‘no’ to that?!

Troajan thank you for sharing this link.

Today’s market response sucks. This is yet another very good update. ITX continues to deliver what it promised and it hitting its growth trajectories consistently. Well done to the team at Itaconix, keep up the good work.

One day the market will wake up to this little gem.

Yes I thought it was odd that they released a trading update in December just 4 weeks short of year end. I agree they have bowed to pressure for calls for an update.

The update is full of positive developments on revenue, gross margin, marketing, raising company profile.

Canaccord Genuity has also published a new research note on Itaconix plc title “Another strong year”

John Shaw has made it clear there will be no US listing. Itaconix are a small company and can not afford the cost. End of story.

Markets now pivoting to expected falls in interest rates in US, Europe and U.K. in 2024 so money will start to flow back into stocks and share including ITX. We know the H2 trading update is about 6 weeks away so there will be news soon.

With the latest October inflation figures showing strong falls in both the US and U.K. I expect growth and tech stocks to be lifted as money flows back in. Itaconix is sitting pretty and I can see the January trading update being a big turning point for us long suffering share holders. GLA.

What surprises me is that those institutional investors who bought in at 5p (250p) aren’t snapping up shares at 3p (150p). I still think ITX is a steal at these prices.

Directors must know this is way into oversold territory and there is a very positive trading update due in January. Be interesting to see if that large purchase shifts the price up this morning. Logically it should but then again logic rarely seems to apply here

Ricky asks a very good question. How did John Shaw buy his shares so cheap? $1.6 converts to £1.32 which is much lower than both the Buy and Sell price!

I wonder if the OTC market has anything to do with the fall in share price? Does that market have access to a pool of cheap ITX shares following the 50:1 reverse split?

When the finance director starts adding shares to their already ridiculously large share holding, you know the bottom is in. Would be nice to see some of the other directors adding. A large purchase by one of the directors would certainly get the price moving

Thanks AJP.

This is a good example of where a RNS could be released to explain the potential applications of this new IP.

Hopefully the new comms guy at Itaconix reads this bulletin board